Although the majority of studies on neurodegenerative diseases and NLRP3 inflammasome show that NLRP3 inhibition is beneficial for the regression of the disease symptoms, two studies at least suggest that outcomes of NLRP3 activation may have a protective role on the symptoms. The gene discussed is NLRP3; the disease is neurodegenerative disease.